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23 Abstract
24 Prenatal androgen exposure affects reproductive functions and has been proposed as an 
25 underlying cause of polycystic ovary syndrome (PCOS). In this study, we aimed to 
26 investigate the impact of prenatal androgen exposure on ovarian lipid metabolism and to 
27 deepen our understanding of steroidogenesis regulation during adulthood. Pregnant rats 
28 were hyperandrogenized with testosterone and female offspring were studied when 
29 adult. This treatment leads to two different phenotypes: irregular ovulatory and 
30 anovulatory animals. Our results showed that prenatally hyperandrogenized (PH) animals 
31 displayed altered lipid and hormonal profile together with alterations in steroidogenesis 
32 and ovarian lipid metabolism. Moreover, PH animals showed alterations in the PPARg 
33 system, impaired mRNA levels of cholesterol receptors (Ldl-r and Srb-1) and decreased 
34 expression of the rate-limiting enzyme of de novo cholesterol production (Hmgcr). 
35 Anovulatory PH animals presented an increase of ovarian cholesteryl esters levels and 
36 lipid peroxidation index. Together with alterations in cholesterol metabolism, we found an 
37 impairment of the steroidogenic pathway in PH animals in a phenotype-specific manner. 
38 Regarding fatty acid metabolism, our results showed, in PH animals, an altered expression 
39 of Srebp1 and Atgl, which are involved in fatty acid metabolism and triglycerides 
40 hydrolysis, respectively. In conclusion, fatty acid and cholesterol metabolism, which are 
41 key players in steroidogenesis acting as a source of energy and substrate for steroid 
42 production, were affected in animals exposed to androgens during gestation. These 
43 results suggest that prenatal androgen exposure leads to long-term effects that affect 
44 ovary lipid metabolism and ovarian steroid formation from the very first steps. 
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45 word count: 4972
46 Introduction
47 Prenatal exposure to androgens during fetal development impacts on several tissues and 
48 leads to reproductive and metabolic alterations during puberty and adulthood (Cardoso & 
49 Padmanabhan 2019). It has been widely shown, in several species, that prenatal androgen 
50 excess can program metabolic, endocrine and reproductive disturbances at postnatal life, 
51 and lead to the development of phenotypes that resemble the features of human 
52 Polycystic Ovary Syndrome (PCOS) (Padmanabhan & Veiga-Lopez 2013). The problems 
53 experienced by women with PCOS include ovarian infertility and reproductive 
54 abnormalities such as altered steroidogenesis (Sander et al. 2011) and impaired ovarian 
55 function (Franks et al. 2008).  
56 It has been shown that the ovary is a target organ of fetal programming effects, 
57 particularly in cases of exposure to androgens during gestation (Puttabyatappa & 
58 Padmanabhan 2018). It is also known that fetal programming may have long-lasting 
59 effects on gene expression and physiological deregulations (Padmanabhan et al. 2016). 
60 However, the long-term impact of androgen excess during gestation on the ovary is still a 
61 matter of study.  
62 The main functions of the ovaries are to produce oocytes and to secrete steroid 
63 hormones, thus regulating and supporting reproductive functions. All of these processes 
64 are mainly, but not exclusively, regulated by hormonal actions, including the action of 
65 gonadotropins and steroid hormones. In this regard, it has been suggested that lipids play 
66 a crucial role in reproductive functions (Kim et al. 2017; Dallel et al. 2018). Moreover, it is 
Page 3 of 40
joe@bioscientifica.com
Manuscript submitted for review to Journal of Endocrinology
For Review Only
67 known that alterations in the metabolic status, such as obesity and dyslipidemia, may 
68 have a negative impact on female fertility (Li & Ma 2018; Silvestris et al. 2018). It has been 
69 reported that lipid pathways are susceptible to being programmed in several tissues, 
70 including reproductive ones (Abruzzese et al. 2016; Calabuig-Navarro et al. 2017). 
71 However, whether prenatal androgen excess may affect ovarian functions and steroid 
72 production through lipid metabolism alterations requires further studies. 
73 In the ovaries, lipids play a major role in reproductive and metabolic functions. 
74 Steroidogenesis, intracellular lipid metabolism, oxidative stress, among other processes, 
75 are controlled by the presence and activity of the Peroxisome proliferator-activated 
76 receptors (PPARs) nuclear receptors. It has been reported that the activation of PPARg 
77 (which includes its binding to PPARg co-activator 1 alpha, or PGC1a) modulates the 
78 synthesis of steroid hormones in granulosa cells. Furthermore, it has been shown that the 
79 disruption of this system has been reported to lead to female subfertility (Vélez et al. 
80 2013).
81 During oogenesis and folliculogenesis, there is an accumulation of large amounts of sterols 
82 and triglycerides (TG). These are used as primary sources for ATP production or the 
83 synthesis of other lipid species (Dunning et al. 2014). Triglycerides are a major energy 
84 source and the predominant form of energy storage in several cell types, together with 
85 fatty acids, normally stored as lipid droplets in ovarian cells (Wu et al. 2010). Fatty acid 
86 and glucose oxidation provides energy substrates for oocyte development and 
87 steroidogenesis (Singh et al. 2013). As it is known that failures in energy metabolism may 
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88 lead to reproductive alterations (Dupont et al. 2018), ovarian lipids play a key role in 
89 ovarian energy balance.
90 Other lipids, such as phospholipids and sterols, have important functions as essential 
91 constituents of biological cell membranes, where they are crucial in membrane structural 
92 and physiological properties. Sterols are the main lipid species in the ovaries. They 
93 participate directly in the steroidogenic process, in which cholesterol acts as the limiting 
94 substratum in ovarian steroid synthesis (van Montfoort et al. 2014). 
95 Moreover, regarding steroidogenesis, cholesterol availability is determinant for hormone 
96 synthesis. Steroidogenic cells of the ovary can obtain cholesterol from blood lipoproteins, 
97 suggested as the major sources, or by de novo synthesis. Steroids are involved in follicular 
98 development, ovulation, and pregnancy maintenance, and also participate in the 
99 regulation of gonadotropin secretion in the systemic circulation (Drummond 2006). 
100 Consequently, alterations in ovarian lipid metabolism may lead to infertility and several 
101 reproductive disorders, such as PCOS, among others (Lai et al. 2014). Taking all this 
102 evidence together, we aimed to investigate the effects of prenatal androgen exposure on 
103 ovarian lipid metabolism and steroidogenesis at adult age. 
104
105 Material and methods
106
107 Animals and treatments
108 Virgin female rats of the Sprague Dawley strain were mated with fertile males of the same 
109 strain. Three females and one male were housed in each cage under controlled conditions 
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110 of light (12 h light, 12 h dark) and temperature (22 ºC). Animals were allowed free access 
111 to Purina rat chow (Cooperación SRL, Argentina) and water. Day 0 of pregnancy was 
112 estimated as the morning on which spermatozoa were observed in the vaginal fluid. As 
113 previously described (Abruzzese et al. 2016, 2019a), pregnant rats (N=10) received 
114 subcutaneous injections of 1 mg of free testosterone (T-1500; Sigma, St. Louis, MO, USA) 
115 dissolved in 100 µl corn oil from day 16 to day 19 of pregnancy. This hormonal paradigm 
116 mimics the fetal androgen surge that is observed in male rats when the reproductive axis 
117 in the fetus is established (Wolf 2002; Ramezani Tehrani et al. 2014). Another group 
118 (N=10) received only 100 µl of corn oil. Under the conditions of our animal facilities, 
119 spontaneous term labor occurs on day 22 of gestation. Female offspring were separated 
120 from males at 21 days of age. Those from hyperandrogenized mothers were the prenatally 
121 hyperandrogenized (PH) group and those from mothers injected with corn oil were the 
122 control group. Previous studies of our group have shown that, in this animal model, the 
123 treatment of the PH group leads to human PCOS like features, with impaired follicle count, 
124 ovarian cysts presence, biochemical hyperandrogenism and altered hormonal and 
125 metabolic profile (Abruzzese et al. 2016, 2019a). 
126 Animals were euthanized by decapitation after anesthesia with carbon dioxide during 
127 adult age (three months of age). Ovaries were extracted, trunk blood was collected and 
128 serum was separated and kept at -80°C for further studies. All animals were randomly 
129 assigned for each assay considering their litter precedence. Care was taken when 
130 assigning and equilibrating the number of animals from each littermate to all the assays to 
131 prevent the maternal effect on the results.
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132 All the procedures involving animals were conducted in accordance with the Animal Care 
133 and Use Committee of Consejo Nacional de Investigaciones Científicas y Técnicas 
134 (CONICET) 1996, Argentina. The present study was approved by the Ethics Committee of 
135 the School of Medicine of University of Buenos Aires. 
136
137 Characterization of the estrous cyclicity 
138 Estrous cycles were monitored daily by vaginal smears beginning at 70 days of age and 
139 until decapitation. As previously reported, the control group had regular cycles (4–6 days), 
140 whereas those animals prenatally exposed to androgens displayed mostly altered estrous 
141 cycles. Vaginal smears showed that 49.5% of the PH animals showed prolonged cycles 
142 lasting 7 days or more and were classified as irregular ovulatory animals (PHiov); and that 
143 40.5% of the animals showed no cycles at all and were classified as anovulatory animals 
144 (PHanov) (Abruzzese et al. 2016; Heber et al. 2019). At three months of age, the entire 
145 PHanov group remained in diestrus; for that reason, and to allow comparison among 
146 groups, all animals were euthanized on the first diestrus after 90 days of age.
147
148 Serum determinations
149 Total cholesterol, high-density lipoprotein (HDL) and TG levels were quantified by 
150 colorimetric-enzymatic methods (Weiner Lab). The chromophoric product was measured 
151 at 505 nm for cholesterol, at 600 nm for HDL and at 490 nm for triglycerides. Low-density 
152 protein (LDL) cholesterol was estimated indirectly by the following formula: LDL = Total 
153 cholesterol - (HDL + Triglycerides/5) (Friedewald et al. 1972).
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154 Luteinizing hormone (LH), follicle stimulating hormone (FSH), testosterone and 
155 progesterone were quantified using radioimmunoassay (RIA), following the protocols 
156 previously described (Lacau-Mengido et al. 1996; Abruzzese et al. 2019a). The intra- and 
157 inter-assay coefficients were less than 10% and 13% for LH and FSH, respectively. The 
158 utility range of testosterone assay was 25–1600 pg. The intra- and inter-assay variations 
159 were 7.5 and 15.1%, respectively. Progesterone antiserum was highly specific for 
160 progesterone and showed low cross-reactivity. The intra- and inter-assay coefficients of 
161 variation were 10.9 and 12.8%, respectively. Serum estradiol levels were quantified with 
162 Cobase immunoassay analyzers using an Electro Chemiluminescence Immuno Assay 
163 (ECLIA) following the manufacturer’s instructions. The intra- and inter-assay coefficients of 
164 variation were 13.2 and 7.08%.
165
166 Ovarian lipid content
167 Lipid content was analyzed by thin layer chromatography (TLC). Both ovaries per animal 
168 were homogenized in 1 ml phosphate-buffered saline (PBS) and protein content in the 
169 homogenates was measured by the Bradford assay. Tissue lipids were extracted from 500 
170 μl of each homogenate by two rounds of organic extraction in methanol: chloroform (2:1), 
171 following the method of Bligh & Dyer (1959). The lipids extracted were developed by thin 
172 layer chromatography in 0.2 mm silica gel plates (Merck, Darmstadt, Germany), using 
173 hexane: ethyl ether: acetic acid (80:20:2, v:v:v) as the developing solvent mixture, as 
174 previously reported (Kurtz et al. 2010). Samples were developed with known amounts of 
175 lipid standards on the same plate. Lipid species were stained with iodine vapors and the 
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176 plate was scanned for further identification and quantification of the lipid species by 
177 comparison with known amounts of standards. Densitometric analysis of the area 
178 intensity of each spot was performed with the ImageJ software. The lipid content was 
179 expressed as ug lipids/mg protein.
180
181 Gene expression analysis
182 In order to assess lipid metabolism, the expression of Pparg and Pgc1 was analyzed. Fatty 
183 acid metabolism and availability from triglycerides was evaluated by measuring mRNA 
184 levels of Srebp1 and Atgl, respectively. To evaluate cholesterol bioavailability, the mRNA 
185 expression of the cholesterol receptors: Ldl-r and Srb1 was assessed, and de novo 
186 cholesterol synthesis was assessed, by measuring the mRNA expression of its limiting 
187 enzyme, 3-hydroxy-3-methylglutaryl-CoA reductase (Hmgcr).
188 All mRNA levels were quantified by Real-Time PCR analysis. Briefly, total mRNA from 
189 ovarian tissue was extracted using RNAzol RT (MRC gene, Molecular Research Center, 
190 Cincinnati, OH, USA), following the manufacturer’s instructions. For each sample, cDNA 
191 was synthesized from 1 μg mRNA using random primer hexamers (Invitrogen-Life 
192 Technologies, Buenos Aires, Argentina). Real-time PCR analysis was performed from this 
193 cDNA (2.5 μL) in 10 μL reaction buffer containing a 20 mM dNTPs mix, GoTaq Polymerase 
194 (Promega), Eva Green 20x (Biotium Hayward, CA, USA) and gene-specific primers in a total 
195 volume of 12.5 μL. The qPCR conditions started with a denaturation step at 95ºC for 5 min 
196 and followed by up to 40 cycles of denaturation (95ºC), annealing (see temperature for 
197 each primer in table 1) and primer extension (72ºC). The amplified products were 
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198 quantified by fluorescence, using the Rotor Gene 6000 Corbett, and mRNA abundance was 
199 normalized to the amount of 60s Ribosomal protein L32 (L32) and Proteasome Subunit 
200 Beta 2 (Psmb2) considering the geometric media. Both L32 and Psmb2 were validated as 
201 reference genes as the variance between treatments did not differ.  In order to check for 
202 DNA contamination, for L32, a control without reverse transcription was included to 
203 ensure that amplification was only from mRNA. All of the amplicons for the different 
204 genes were characterized according to their melting temperature and size. Each qPCR run 
205 included a no-template control. The reaction conditions and quantities of cDNA added 
206 were calibrated such that the assay response was linear with respect to the amount of 
207 input cDNA for each pair of primers. Gene expression was quantified using the 2 –ΔΔCt 
208 method (Livak & Schmittgen 2001). Results are expressed as a fold value of the controls. 
209 The primers are shown in Table 1.
210
211 Protein expression analysis
212 Protein expression in ovarian tissue was determined by Western blot analysis. Briefly, 
213 ovarian tissue was lysed for 20 min at 4 ºC in lysis buffer (20 mM Tris-HCl, pH= 8.0, 137 
214 mM NaCl, 1% Nonidet P-40 and 10% glycerol) supplemented with protease inhibitors 
215 (Sigma-Aldrich, St. Louis, MO, USA). The lysate was centrifuged at 4 ºC for 10 min at 
216 10,000 g and the pellet discarded. Protein concentrations in the supernatant were 
217 measured by the Bradford assay (Bio-Rad, Hercules, CA, USA). After boiling for 5 min, 30 
218 μg of each protein was applied to a 12% SDS-polyacrylamide gel and electrophoresis was 
219 performed at 80 Volts for 1.5 h. The separated proteins were transferred onto 
Page 10 of 40
joe@bioscientifica.com
Manuscript submitted for review to Journal of Endocrinology
For Review Only
220 nitrocellulose membranes in transfer buffer (20% methanol, vol/vol; 0.19 M glycine; 0.025 
221 M Tris-Base, pH= 8.3) for 1 h at 400 mA and 4 ºC. Blocking was carried out for 1 h at room 
222 temperature in 5% non-fat milk in PBS and membranes were incubated with the primary 
223 antibody (Table 2), diluted in 1% bovine serum albumin in PBS, overnight at 4 ºC. The 
224 protein bands were visualized by incubating the blots with horseradish peroxidase-
225 conjugated secondary antibody Goat anti-rabbit IgG IgG H&L, HRP (1:1500, #1706515, 
226 BioRad) or anti-mouse IgG HRP (1:5000, ab6728, Abcam) for 1 h, followed by ECL Western 
227 Blotting Substrate (Thermo Scientific, IL, USA). Rainbow-colored protein mass markers 
228 (14.3-200 kDa, Bio-Rad) were applied to samples as molecular weight standards.
229 The consistency of protein loading was evaluated by staining the membranes with 
230 Ponceau-S. The expression of the target proteins was normalized for total protein staining 
231 to adjust for unequal loading. The images were captured in a chemiluminescence imaging 
232 system (GeneGnomeXRQ, Syngene), and the intensities (area x density) of the individual 
233 bands were evaluated with ImageJ software. When quantified, the intensity of each 
234 protein band was normalized to the total protein in individual samples to adjust for 
235 unequal loading and transfer (Roberti et al. 2018). 
236
237 Co-Immunoprecipitation (co-IP) of PPARg and PGC1a
238 To evaluate PPARg interaction with its co-activator PGC1a, a co-immunoprecipitation was 
239 performed. Ovarian tissue (25 mg for each sample) was homogenized in 500ul of non-
240 denaturing lysis buffer (200mM Tris-HCl pH=8, 137 mM NaCl, 10% glycerol, % NP-40, 2nM 
241 EDTA pH=8) supplemented with protease inhibitors (Sigma, USA). Lysate was incubated in 
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242 agitation during 2hs at 4°C. After a centrifugation at 10000g, supernatant was recovered 
243 and 1 ug of anti PPARg1+2 (ab41928,Abcam, UK) was added to the samples, and 
244 incubated overnight in agitation at 4°C. Antibody complexes were precipitated using 
245 Protein G Plus Agarose (Santa Cruz) overnight at 4°C.  Complexes were pelleted and 
246 washed 3 times in modified RIPA buffer (50 mM Tris-HCl pH=8, 150 mM NaCl, 2 mM EDTA 
247 pH=8, 1% NP-40, 0,5% sodium deoxycholate, 0,2% SDS) containing protease inhibitors to 
248 eliminate non-specific interactions. After the last wash, all the samples were resuspended 
249 in 50 ul of 2X Laemli buffer (4% SDS, 20% glycerol, 0,004% bromophenol blue, 0,125M 
250 Tris-Cl pH= 6,8, 10% 2-mercaptoethanol) which was added to the precipitated containing 
251 the beads and bound protein complexes and the beads were denatured by boiling at 95°C 
252 for 7 minutes. Samples were analyzed by Western blot to identify the coprecipitating 
253 effector protein using PGC1a antibody (sc13067, Santa Cruz Biotechnology, USA), as 
254 described above. 
255
256 Lipid peroxidation
257 The amount of malondialdehyde (MDA) formed from the breakdown of polyunsaturated 
258 fatty acids was taken as an index of peroxidation reaction. The method quantifies MDA as 
259 the product of lipid peroxidation that reacts with trichloracetic acid–thiobarbituric acid–
260 HCl (15% (w/v), 0.375% (w/v) and 0.25 M, respectively) yielding a red compound that 
261 absorbs at 535nm (Motta et al. 2001). Homogenates of ovarian tissue were treated with 
262 trichloroacetic acid–thiobarbituric acid–HCl and heated for 15 min in boiling water bath. 
263 After cooling, the flocculent precipitate was removed by centrifugation at 1000 g for 10 
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264 min. The absorbance of samples was determined at 535 nm. Content of thiobarbituric acid 
265 reactants were expressed as nmol MDA formed/g tissue.
266
267 Statistical analysis
268 Data was analyzed by ANOVA with post hoc Tukey test. Data normality was checked using 
269 the Shapiro-Wilks test. The equality of variance was tested using the Levene test. If 
270 required, Log10 transformation was used to normalize the distribution of data and to the 
271 statistical analysis. Data were back-transformed for presentation. Statistical significance 
272 was considered as p<0.05. The sample size for the experimental procedures was 
273 calculated using  G*power 3 (Faul et al. 2007). Statistical analyses were carried out using 
274 the Instat program (GraphPad Software, San Diego, CA, USA). 
275
276 Results
277 Hormonal and metabolic determinations 
278 Prenatal androgenization did not affect the body weight at three months of age, while 
279 ovarian weight was decreased in the PHanov phenotype (Table 3). Similar to our previous 
280 findings (Abruzzese et al. 2019b), lipid profile was altered at adulthood in PH animals, 
281 which showed increased levels of LDL-cholesterol (p<0.01) and TG (p<0.01) as compared 
282 with the control group. Regarding hormonal steroid profile, as previously found (Heber et 
283 al. 2019), prenatal androgenization led to an increase in testosterone levels in the PHanov 
284 group (p<0.01) and a decrease in estradiol levels in both PHiov and PHanov groups 
285 (p<0.05), without alterations in progesterone levels (p>0.05). Moreover, neither of the PH 
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286 groups showed altered levels of the gonadotropins FSH and LH as compared to the control 
287 group (p>0.05).
288
289 Ovary lipid content
290 We found no changes in ovarian TG, fatty acids and phospholipids ovary content in the PH 
291 group as compared to the control group (Fig.1A, B and C, respectively, p>0.05). Regarding 
292 cholesterol content, we found no differences in the PH group as compared to control 
293 group (Fig.1D, p<0.05), but found higher levels of cholesteryl esters in the PHanov 
294 phenotype as compared to the PHiov and control groups (Fig.1E, p<0.05).  
295
296 Ovarian lipid metabolism 
297 Prenatal androgenization affected PPARg and its coactivator (PGC1a) expression and 
298 interaction. We found a decrease in PPARg mRNA (Fig. 2A, p<0.01) and protein levels (Fig. 
299 2B, p<0.05) in the PH phenotypes as compared to the control group. Moreover, PGC1a 
300 mRNA and protein levels (Fig. 2C and D, p<0.05) were decreased in the PHiov phenotype. 
301 Co-immunoprecipitation results showed a decreased interaction between PPARg and 
302 PGC1a in the PH phenotypes as compared to controls (Fig. 2E, p<0.05).
303 Fatty acid metabolism was also impaired by prenatal androgen exposure. We found that 
304 the mRNA levels of the master regulator of fatty acid metabolism Srebp1 were decreased 
305 in both PH phenotypes as compared to the control group (Fig. 3A, p<0.01). Moreover, we 
306 found that the mRNA levels of Atgl, a key enzyme involved in the initial step of 
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307 intracellular hydrolysis of TG, were increased in both PH phenotypes, with the highest 
308 levels in the PHiov phenotype (Fig. 3B, p<0.01).
309 We also found that prenatal androgenization altered ovarian cholesterol pathway. Our 
310 results showed that the cholesterol receptors, LDL-R and SRB1, were altered in the PH 
311 groups. In the case of the PHanov phenotype, the mRNA levels of Ldl-r were increased 
312 (Fig. 4A, p<0.01), while in the PHiov phenotype, the mRNA levels of Srb1 were decreased 
313 (Fig. 4B, p<0.05). Moreover, the mRNA levels of Hmgcr, a key enzyme in cholesterol de 
314 novo synthesis, were lower in the PH group than in the control group (Fig 4C, p<0.01).
315
316 Ovarian lipid peroxidation
317 The lipid peroxidation index was evaluated by the content of ovarian MDA. We found that 
318 lipid peroxidation index was increased in the PHanov phenotype as compared to the 
319 control group (Fig. 5, p<0.05).  
320
321 Ovarian steroidogenesis 
322 Ovarian steroidogenic pathway was evaluated to study the relation between 
323 steroidogenesis and lipid metabolism (Fig 6). The protein levels of StAR were increased in 
324 the PHanov phenotype (p<0.05). The protein levels of 3BHSD and CYP17, limiting enzymes 
325 in progesterone and androgen synthesis, respectively, remained unaltered in the PH 
326 phenotypes (p>0.05). The protein levels of 17BHSD, involved in testosterone synthesis, 
327 were decreased in the PHanov phenotype and showed a tendency to decrease in the 
328 PHiov phenotype (p<0.05). The protein levels of CYP19 (aromatase), involved in estradiol 
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329 synthesis, were increased in the PHiov phenotype and showed a tendency to increase in 
330 the PHanov phenotype (p<0.05).
331 Discussion
332 Reproductive functions depend on hormonal regulation and also on energy storage and 
333 availability. Lipids play important roles in ovarian functions, acting as sources of energy, 
334 and as substrates for several intracellular processes (Dallel et al. 2018). 
335 Prenatal exposure to a suboptimal intrauterine environment could lead to long term 
336 effects affecting reproductive functions. To study the impact of fetal programming of 
337 animals exposed to androgens, we reproduced a rodent model of prenatal androgen 
338 excess widely used (Wolf 2002; Ramezani Tehrani et al. 2014; Abruzzese et al. 2016, 
339 2019a, b; Heber et al. 2019). Here, using this model, we addressed the question of 
340 whether ovarian lipid metabolism and specifically cholesterol metabolism are impaired in 
341 these animals when adults.
342 Prenatal androgen exposure may negatively impact on gonadal development, conditioning 
343 its growth and functions in postnatal life. In this regard, we found a decreased ovarian 
344 weight in the PHanov phenotype, which could account, at least in part, for the more 
345 severe ovarian defects found in this phenotype. 
346 In this animal model, the lipid profile was found altered together with an imbalance in 
347 steroid hormone profile, thus highlighting the effect of steroid hormones on lipid 
348 metabolism (Kakuta et al. 2013; Meng et al. 2015). We found no changes in gonadotropins 
349 levels, as we have previously reported at pubertal age (Abruzzese et al. 2019a). However, 
350 although gonadotropins levels may remain unaltered, defects in their pulsatility are 
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351 possible (Yan et al. 2014). Moreover, it is important to highlight that, together with 
352 gonadotropins, lipids and insulin are also involved in ovarian steroid production. In this 
353 regard, we have previously shown that PH animals show insulin resistance and impaired 
354 ovarian insulin signaling (Heber et al. 2019); and here, we report that ovarian lipid 
355 pathways are also affected. Taking together, these data highlight the role of energetic 
356 ovarian defects, as those given by alterations on lipids and insulin pathways, as 
357 contributing factors to altered steroid production in hyperandrogenic contexts.
358 The master regulator of lipid metabolism PPARg is also involved in female reproductive 
359 functions, and particularly it has been reported that PPARg regulates steroidogenic 
360 enzymes (Vélez et al. 2013). Alterations in PPARg system have already been reported in 
361 PCOS patients and animal models (Chen et al. 2015a; Cao et al. 2019). Here, we found that 
362 the expression of PPARg and its co-activator, PCG-1a, are decreased in PH animals. 
363 Moreover, we found that PPARg activation was decreased in these animals. These results 
364 extend our previous findings about the role of PPARg system in androgenic contexts 
365 (Abruzzese et al. 2019a). This evidence shows that this system's expression pattern could 
366 change across different life stages in PH animals during post-natal life (Abruzzese et al. 
367 2019a), as it has already been suggested in sheep (Ortega et al. 2010). In accordance with 
368 our results, it has been shown that PCOS adult women show a downregulation of PPARg 
369 expression in ovarian granulosa cells (Cao et al. 2019), and that the treatment with 
370 thiazolidinediones (high-affinity ligands for PPARg that lead to its activation) has positive 
371 effects on reproductive function and ovulation rate in these patients (Froment & Touraine 
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372 2006). These results suggest that, in androgenic contexts, PPARg system activation may be 
373 impaired and highlights the crucial role of this system in ovarian functions. 
374 During oogenesis, maturing oocytes accumulate neutral lipids that are essential for both 
375 energy production and synthesis of other lipid molecules. For example, fatty acids are 
376 used as an energy source during oocyte maturation. Here, we showed that although fatty 
377 acid content was not altered in the ovaries of the PH group, fatty acid metabolism was 
378 impaired. Gene expression of Srebp1, which regulates several genes involved in fatty acid 
379 synthesis, was decreased in PH animals. On the other hand, mRNA expression of Atgl, 
380 which participates in the initial steps in triglycerides hydrolysis, was increased in the PH 
381 group. Taken together, these results suggest that although prenatal androgenization 
382 affected fatty acid synthesis, there is compensation between two different pathways for 
383 obtaining fatty acids. 
384 Oxidative stress is associated with decreased female fertility. In particular, fatty acid 
385 peroxidation has been suggested as one of the main sources that can affect gamete 
386 viability, negatively impacting fertility (Agarwal et al. 2012). Ovarian oxidative stress plays 
387 a crucial role in PCOS, ovarian senescence and age-related decline of reproductive 
388 function (Yildirim et al. 2007; Aiken et al. 2013). Moreover, it has been shown that 
389 testosterone has pro-oxidant properties and is able to induce oxidative stress in different 
390 mammalian tissues, as for example, in female placenta (Zhu et al. 1997; Alonso-Alvarez et 
391 al. 2007). In this study, we found that the anovulatory phenotype showed increased levels 
392 of lipid peroxidation. This result shows that increased testosterone exposure during 
393 development and postnatal life could lead to an increased lipid peroxidation, contributing 
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394 to the reproductive alterations and infertility already reported in this phenotype (Ferreira 
395 et al. 2019).
396 Cholesterol is essential for ovarian steroidogenesis (Strauss 2019). Ovarian tissue may 
397 synthesize de novo cholesterol being HMGCR a limiting enzyme in this process. The role of 
398 HMGCR in PCOS pathology has been highlighted in other studies. In this regard, in a 
399 murine model of PCOS, it was shown a repression in the transcription of HMGCR, and 
400 other genes involved in lipid metabolism (Salilew-Wondim et al. 2015). Moreover, in PCOS 
401 patients, it has been described that Hmgcr may act as a modifier gene in PCOS (Xu et al. 
402 2010). Together with these findings, it has been shown that HMGCR expression, at least in 
403 hepatic cells, can be induced by estrogenic action, as the Hmgcr promoter has estrogen 
404 response elements (Meng et al. 2015). Therefore, low levels of estradiol in the PH animals 
405 could account for the decreased expression of Hmgcr that we found.
406 Despite the possibility of de novo cholesterol synthesis, as there is a high demand in 
407 cholesterol bioavailability in steroidogenic cells, it may also be captured from plasma 
408 involving two different receptors: LDL-R and SR-B1 (Wang & Menon 2005; Lai et al. 2014). 
409 In rodents, it has been reported that both receptors are important in cholesterol 
410 trafficking and steroid biosynthesis (Chang et al. 2017). It has been shown that female 
411 mice knockout for Sr-b1 or Ldl-r are infertile (Miettinen et al. 2001) or show alterations in 
412 the estrous cycle, steroidogenesis and folliculogenesis (Guo et al. 2015). In accordance 
413 with these data, our results showed that the PH animals presented an altered expression 
414 of ovarian cholesterol receptors. These results indicate that in both PH phenotypes, 
415 ovarian cholesterol trafficking pathway is altered. In the case of PHanov animals, the 
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416 entering of cholesterol to the cell would be promoted in the PHanov phenotype due to 
417 the increase in Ldl-r mRNA levels. While in the PHiov phenotype, cholesterol entrance is 
418 also altered, showing a decrease in Sr-b1 mRNA levels, but no alterations in Ldl-r 
419 expression, suggesting that LDL cholesterol may be used as a preferential source for 
420 steroidogenesis. It has been reported that knock-out Srb1 female mice are infertile but do 
421 not exhibit estrous cycle defects or altered number of ovulated oocytes  (Trigatti et al. 
422 1999). Moreover, testosterone (Langer et al. 2002) and estradiol (Lopez et al. 2002) can 
423 up-regulate Srb1 expression, and it was shown that some mutations of Srb1 that affect 
424 this gene expression, decreasing it, are associated with low estradiol levels (Strauss 2019). 
425 In agreement with these reports, our PHiov animals showed low expression of Srb1 and 
426 also low levels of estradiol. However, as we have shown in a previous report, these 
427 animals are able to become pregnant but with a lower efficacy than control females, 
428 showing some degree of subfertility (Ferreira et al. 2019). The different expression of Srb1 
429 between PHanov and PHiov animals may be due to the testosterone and estradiol levels, 
430 while both PH groups showed low estradiol levels, PHanov animals showed high 
431 testosterone, which could be acting up-regulating Srb1 expression and therefore 
432 contributing to high cholesterol trafficking in the ovaries of these animals.
433 The quantity of sterol ester stored depends on the availability of cholesterol and the cell's 
434 steroidogenic activity. In steroidogenic cells such as ovary and testis, the formation of lipid 
435 droplets is hormonally regulated (Hu et al. 2010); therefore, alterations in hormone 
436 production or levels could affect cholesterol esterification and lipid droplets depot 
437 (Strauss 2019). In our animal model, we found that PH animals had altered hormonal 
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438 balance together with impaired ovarian steroid production. Particularly, in the PHanov 
439 phenotype, we found an increase in cholesterol esters. This increase in cholesterol 
440 esterification in this phenotype is probably related to the increased intake of cholesterol 
441 through Ldl-r and testosterone synthesis. 
442 All of these derangements in the cholesterol pathway and the PPARg system also affected 
443 steroidogenesis. When we analyzed steroidogenic mediators, we found alterations in 
444 several of them in a phenotype-specific manner. In the PHiov phenotype, little alterations 
445 were found regarding steroidogenesis. However, the fact that the protein expression of 
446 17BHSD tended to decrease is consistent with the lack of increased testosterone levels. 
447 This phenotype also showed low estradiol levels despite increased CYP19 (aromatase) 
448 protein expression. This could be due to defects in aromatase activity, which have been 
449 previously reported in PCOS women (Chen et al. 2015b). Taking all of these together, the 
450 decreased estradiol levels could contribute to an altered hormonal balance that may 
451 influence reproductive functions in this phenotype.  
452 In the PHanov phenotype, we found alterations in StAR, 17BHSD and CYP19 protein 
453 expression. This phenotype exhibited a favoring to high steroid synthesis, as shown by 
454 increased StAR protein expression, consistent with the increased testosterone levels 
455 found. However, unexpectedly, we found a decreased protein expression of 17BHSD. A 
456 possibility is that although enzyme expression is down, its activity may be increased. 
457 Similar to our findings, other authors have also reported this paradoxical result regarding 
458 the decreased expression of enzymes involved in androgen synthesis and increased 
459 androgen production (Ortega et al. 2013; Padmanabhan et al. 2014).
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460 It is important to highlight that although the steroidogenic factors and enzymes were also 
461 altered at early stages of life (Abruzzese et al. 2019a), here, we found that at adulthood, 
462 the pattern is changed as compared with that observed at 60 days of age. These results 
463 suggest that the long term effects of developmental programming by androgen excess 
464 may change through life. These data are consistent with a report from Padmanabhan et al. 
465 (2014) in prenatally androgenized sheep, who also found that steroidogenic mediators are 
466 altered and change in an age-specific manner  (Padmanabhan et al. 2014).    
467 In conclusion, our results show that prenatal androgen excess exerts long-term effects on 
468 ovarian functions affecting ovarian lipid metabolism and particularly affecting the 
469 steroidogenic pathway from the very first steps involving cholesterol availability and 
470 synthesis.
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679 Figure legends
680 Figure 1. Effects of prenatal androgen exposure on lipid concentrations in the ovaries of 
681 prenatally hyperandrogenized (PH) and control groups. A) Triglycerides, B) Free fatty 
682 acids, C) Phospholipids, D) Cholesterol E) Cholesteryl esters. White dots correspond to 
683 animals of the control group (n=6), grey dots to the PHiov phenotype (n=6), and black dots 
684 to the PHanov phenotype (n=6). The horizontal bar represents the mean. Statistical 
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685 analyses were made by ANOVA; different letters mean statistically significant differences 
686 (a vs. b, p<0.05).
687
688 Figure 2. Effects of prenatal androgen exposure on PPARg system in the ovaries of 
689 prenatally hyperandrogenized (PH) and control groups. The graphs correspond to A) 
690 mRNA abundance of Pparg (p < 0.01), B) protein levels of PPARg (p < 0.05), C) mRNA levels 
691 of Pgc1a (p < 0.01), D) protein levels of PGC1a (p < 0.05), and E) Co-immunoprecipitation 
692 of PPARg and PGC1a in ovaries of the prenatally hyperandrogenized (PH) and control 
693 groups. White dots correspond to animals of the control group, grey dots to the PHiov 
694 phenotype, and black dots to the PHanov phenotype. The horizontal bar represents the 
695 mean.  A sample size of 6 animals per group was used for mRNA and protein analysis and 
696 5 animals per group for CO-IP analysis. Statistical analyses were made by ANOVA; different 
697 letters mean statistically significant differences (a vs. b, p < 0.05).
698
699 Figure 3. Effects of prenatal androgenization on fatty acid and triacylglycerol metabolism.  
700 The graphs correspond to A) mRNA abundance of Srebp1 (p<0.01), B) mRNA abundance of 
701 Atgl (p<0.01) of the prenatally hyperandrogenized (PH) and control groups. White dots 
702 correspond to animals of the control group (n=6), grey dots to the PHiov phenotype (n=6), 
703 and black dots to the PHanov phenotype (n=6). The horizontal bar represents the mean. 
704 Statistical analyses were made by ANOVA; different letters mean statistically significant 
705 differences (a vs. b, p<0.05).
706
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707 Figure 4. Prenatal androgenization effects on ovarian cholesterol pathway. The graphs 
708 correspond to A) mRNA abundance of Ldl-r (p<0.01), B) mRNA abundance of Srb1 
709 (p<0.05), C) mRNA abundance of Hmgcr (p<0.01) of the prenatally hyperandrogenized 
710 (PH) and control groups. White dots correspond to animals of the control group (n=6), 
711 grey dots to the PHiov phenotype (n=6), and black dots to the PHanov phenotype (n=6). 
712 The horizontal bar represents the mean. Statistical analyses were made by ANOVA; 
713 different letters mean statistically significant differences (a vs. b, p<0.05).
714
715 Figure 5. Prenatal androgenization effects on ovarian lipid peroxidation. 
716 Lipoperoxidation index using the thiobarbituric acid method (TBARS) through the 
717 evaluation of malondialdehyde (MDA) was measured in the prenatally hyperandrogenized 
718 (PH) and control groups. White dots correspond to animals of the control group (n=7), 
719 grey dots to the PHiov phenotype (n=7), and black dots to the PHanov phenotype (n=7). 
720 The horizontal bar represents the mean. Statistical analyses were made by ANOVA; 
721 different letters mean statistically significant differences (a vs. b, p<0.05).
722
723 Figure 6. Prenatal androgen excess effects on ovarian steroidogenic factors and enzymes. 
724 Protein expression of A) Steroidogenic acute regulator (StAR), B) 3-B-Hydroxysteriod 
725 dehydrogenase (3BHSD), C) cytochrome P450 17a-hydroxylase (CYP17), D) 17β-
726 hydroxysteroid dehydrogenase (17BHSD) and E) cytochrome P450 aromatase (CYP19) in 
727 the ovaries of the prenatally hyperandrogenized (PH) and control animals. White dots 
728 correspond to animals of the control group (n=6), grey dots to the PHiov phenotype (n=6), 
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729 and black dots to the PHanov phenotype (n=6). The horizontal bar represents the mean. 
730 Statistical analyses were made by ANOVA; different letters mean statistically significant 
731 differences (a vs. b, p<0.05).
732
733 Table 1. List of primers used in real-time PCR. F, forward sequence; R, reverse sequence.
734
735 Table 2. List of primary antibodies and dilution used for western blotting.
736
737 Table 3. Metabolic and hormonal parameters at adulthood for the prenatally 
738 hyperandrogenized (PH) and control groups for 7 rats per group. Values represent mean ± 
739 S.D. Statistical analyses were made by ANOVA with post hoc Tukey's test. Different letters 
740 mean statistically significant differences (a vs. b, p<0.05).
741
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Table 1. List of primers used in Real-time PCR 
F, forward sequence; R, reverse sequence
Primers used in Real-time PCR
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Table 2. List of primary antibodies and dilution used for western blotting.




PPARg ABCAM ab19481 1:200
PGC1a Santa Cruz 
Biotechnology
sc13067 1:200
StAR Santa Cruz 
Biotechnology
sc25806 1:200
3BHSD Santa Cruz 
Biotechnology
sc28206 1:200
17BHSD Santa Cruz 
Biotechnology
Sc32872 1:200
CYP17 Santa Cruz 
Biotechnology
Sc66849 1:200
CYP19 Santa Cruz 
Biotechnology
Sc30086 1:200
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Table 3. Metabolic and hormonal characterization at adulthood.
Metabolic and hormonal parameters for the prenatally hyperandrogenized (PH) and Control 
groups for 7 rats per group. Values represent mean ± S.D. Statistical analyses were made by 
ANOVA with post hoc Tukey's test. Different letters mean statistically significant differences (a vs. 
b, p<0.05).
Parameter Control PHiov PHanov
Body weight  at 90 days of age (g) 228.33 ± 19.03a 225.22 ± 21.27 a 229.89 ± 26.78 a
Average Ovarian Weight (mg) 46.3 ± 10.44 a 46.82 ± 8.77 a 36.58 ± 4.75 b
Total Cholesterol (mg/dL) 132.03 ± 23.75 a 136.78 ± 39.69 a 128.94 ± 35.97 a
HDL Cholesterol (mg/dL) 31.72 ± 4.49 a 28.53 ± 5.83 a 32.16 ± 5.06 a
LDL Cholesterol (mg/dL) 58.44 ± 21.99 a 105.20 ± 28.37 b 97.20 ± 38.17 b
Triglycerides (mg/dL) 86.08 ± 31.89 a 119.00 ± 24.59 b 112.42 ± 12.03 b
LH (ng/mL) 0.31 ±0.05 a 0.61 ± 0.29 a 0.45 ± 0.34 a
FSH (ng/mL) 3.54 ± 2.06 a 3.43 ± 1.29 a 4.23 ± 2.61 a
Progesterone (ng/mL) 8.16 ± 5.52 a 17.16 ± 9.72 a 12.86 ± 9.6 a
Testosterone (pg/mL) 75.05 ± 18.29 a 93.59 ± 17.26 a 213.23 ± 11.00 b
Estradiol (pg/mL) 14.28 ± 4.66 a 7.69 ± 3.19 b 7.34 ± 2.56 b
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Figure 1. Effects of prenatal androgen exposure on lipid concentrations in the ovaries of prenatally 
hyperandrogenized (PH) and control groups. A) Triglycerides, B) Free fatty acids, C) Phospholipids, D) 
Cholesterol E) Cholesteryl esters. White dots correspond to animals of the control group (n=6), grey dots to 
the PHiov phenotype (n=6), and black dots to the PHanov phenotype (n=6). The horizontal bar represents 
the mean. Statistical analyses were made by ANOVA; different letters mean statistically significant 
differences (a vs. b, p<0.05). 
150x87mm (1200 x 1200 DPI) 
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Figure 2. Effects of prenatal androgen exposure on PPARg system in the ovaries of prenatally 
hyperandrogenized (PH) and control groups. The graphs correspond to A) mRNA abundance of Pparg (p < 
0.01), B) protein levels of PPARg (p < 0.05), C) mRNA levels of Pgc1a (p < 0.01), D) protein levels of 
PGC1a (p < 0.05), and E) Co-immunoprecipitation of PPARg and PGC1a in ovaries of the prenatally 
hyperandrogenized (PH) and control groups. White dots correspond to animals of the control group, grey 
dots to the PHiov phenotype, and black dots to the PHanov phenotype. The horizontal bar represents the 
mean.  A sample size of 6 animals per group was used for mRNA and protein analysis and 5 animals per 
group for CO-IP analysis. Statistical analyses were made by ANOVA; different letters mean statistically 
significant differences (a vs. b, p < 0.05). 
100x144mm (1200 x 1200 DPI) 
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Figure 3. Effects of prenatal androgenization on fatty acid and triacylglycerol metabolism.  The graphs 
correspond to A) mRNA abundance of Srebp1 (p<0.01), B) mRNA abundance of Atgl (p<0.01) of the 
prenatally hyperandrogenized (PH) and control groups. White dots correspond to animals of the control 
group (n=6), grey dots to the PHiov phenotype (n=6), and black dots to the PHanov phenotype (n=6). The 
horizontal bar represents the mean. Statistical analyses were made by ANOVA; different letters mean 
statistically significant differences (a vs. b, p<0.05). 
99x33mm (1200 x 1200 DPI) 
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Figure 4. Prenatal androgenization effects on ovarian cholesterol pathway. The graphs correspond to A) 
mRNA abundance of Ldl-r (p<0.01), B) mRNA abundance of Srb1 (p<0.05), C) mRNA abundance of Hmgcr 
(p<0.01) of the prenatally hyperandrogenized (PH) and control groups. White dots correspond to animals of 
the control group (n=6), grey dots to the PHiov phenotype (n=6), and black dots to the PHanov phenotype 
(n=6). The horizontal bar represents the mean. Statistical analyses were made by ANOVA; different letters 
mean statistically significant differences (a vs. b, p<0.05). 
99x24mm (1200 x 1200 DPI) 
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Figure 5. Prenatal androgenization effects on ovarian lipid peroxidation. 
Lipoperoxidation index using the thiobarbituric acid method (TBARS) through the evaluation of 
malondialdehyde (MDA) was measured in the prenatally hyperandrogenized (PH) and control groups. White 
dots correspond to animals of the control group (n=7), grey dots to the PHiov phenotype (n=7), and black 
dots to the PHanov phenotype (n=7). The horizontal bar represents the mean. Statistical analyses were 
made by ANOVA; different letters mean statistically significant differences (a vs. b, p<0.05). 
49x31mm (1200 x 1200 DPI) 
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Figure 6. Prenatal androgen excess effects on ovarian steroidogenic factors and enzymes. Protein expression 
of A) Steroidogenic acute regulator (StAR), B) 3-B-Hydroxysteriod dehydrogenase (3BHSD), C) cytochrome 
P450 17a-hydroxylase (CYP17), D) 17β-hydroxysteroid dehydrogenase (17BHSD) and E) cytochrome P450 
aromatase (CYP19) in the ovaries of the prenatally hyperandrogenized (PH) and control animals. White dots 
correspond to animals of the control group (n=6), grey dots to the PHiov phenotype (n=6), and black dots 
to the PHanov phenotype (n=6). The horizontal bar represents the mean. Statistical analyses were made by 
ANOVA; different letters mean statistically significant differences (a vs. b, p<0.05). 
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